BRIEF-Royal Bank Of Canada Completes Acquisition Of HSBC Bank Canada-May 2024-www.financetom.com

BRIEF-Royal Bank Of Canada Completes Acquisition Of HSBC Bank Canada

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Royal Bank Of Canada Completes Acquisition Of HSBC Bank Canada

Apr 1, 2024 11:55 PM

April 2 (Reuters) - Royal Bank of Canada ( RY ):

* ROYAL BANK OF CANADA ( RY ) - RBC COMPLETES ACQUISITION OF HSBC

BANK

CANADA

Source text for Eikon:

Further company coverage:

Previous page： Johnson & Johnson Completes Acquisition of Yellow Jersey Therapeutics Next page： Delta Air Lines Q2 Earnings: EPS Miss, Revenue Beat, Underwhelming Q3 EPS Outlook And More

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Johnson & Johnson Completes Acquisition of Yellow Jersey Therapeutics

Jul 11, 2024

07:59 AM EDT, 07/11/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Thursday that it has completed its acquisition of Yellow Jersey, a de-merged subsidiary of Numab Therapeutics, in an all-cash transaction worth approximately $1.25 billion. The pharmaceutical giant said the aim of the acquisition was to obtain the global rights to NM26, an investigational drug intended to...

Delta Air Lines Q2 Earnings: EPS Miss, Revenue Beat, Underwhelming Q3 EPS Outlook And More

Jul 11, 2024

Delta Air Lines, Inc. ( DAL ) shares are trading lower by ~9% premarket on Thursday following the release of its second-quarter 2024 results. Delta reported second-quarter 2024 operating revenue growth of 7% year-over-year to $16.658 billion, beating the consensus of $15.452 billion. Adjusted operating revenue was $15.407 billion (+5.4% YoY). Adjusted average fuel price of $2.64 per gallon, up...

Satellos Bioscience Submits Regulatory Filing for Phase 1 Clinical Trial With SAT-3247

Jul 11, 2024

07:55 AM EDT, 07/11/2024 (MT Newswires) -- Satellos Bioscience ( MSCLF ) filed a clinical research proposal to Australia's health regulator for permission to conduct a first-in-human Phase 1 clinical trial of SAT-3247, a proprietary, oral small molecule drug being being developed to regenerate skeletal muscle lost in Duchenne muscular dystrophy (DMD) and other degenerative diseases or injuries. The Phase...

Cyngn Expands Dealer Network to Include Alta Equipment Group

Jul 11, 2024

07:58 AM EDT, 07/11/2024 (MT Newswires) -- Cyngn ( CYN ) said Thursday it has expanded its dealer network to include Alta Equipment Group ( ALTG ). Alta Equipment ( ALTG ), a construction and material handling equipment seller, will now offer Cyngn's ( CYN ) DriveMod Tugger, an autonomous vehicle service combined with Motrec's MT-160. The company said it...